Rebeca J Kim
Overview
Explore the profile of Rebeca J Kim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
128
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Arsalan M, Ungchusri E, Farkas R, Johnson M, Kim R, Filardo G, et al.
Proc (Bayl Univ Med Cent)
. 2018 May;
31(2):171-176.
PMID: 29706810
Acute kidney injury (AKI) following transcatheter aortic valve implantation (TAVI) is associated with increased morbidity and mortality. The biomarkers neutrophil gelatinase-associated lipocalin (NGAL), kidney injury molecule-1 (KIM-1), and interleukin-18 (IL-18)...
2.
Szerlip M, Arsalan M, Mack M, Filardo G, Worley C, Kim R, et al.
Am J Cardiol
. 2017 Sep;
120(8):1366-1372.
PMID: 28865895
We aim to evaluate the contemporary role and outcomes of balloon aortic valvuloplasty (BAV), based on physician intent, for the management of severe aortic stenosis. This is a prospective, 2-center...
3.
Szerlip M, Kim R, Adeniyi T, Thourani V, Babaliaros V, Bavaria J, et al.
Catheter Cardiovasc Interv
. 2016 Mar;
87(7):1314-21.
PMID: 26946240
Objectives: To examine whether transcatheter aortic valve replacement (TAVR) is a safe and effective treatment option for aortic stenosis in patients with end-stage renal disease (ESRD). Background: Patients with ESRD...
4.
Mack M, Szerlip M, Herbert M, Akram S, Worley C, Kim R, et al.
Ann Thorac Surg
. 2015 May;
100(1):74-80.
PMID: 26013708
Background: Because nonagenarians with aortic stenosis (AS) often present as frail with more comorbid conditions, long-term outcomes and quality of life are important treatment considerations. The aim of this report...
5.
Green P, Arnold S, Cohen D, Kirtane A, Kodali S, Brown D, et al.
Am J Cardiol
. 2015 May;
116(2):264-9.
PMID: 25963221
Transcatheter aortic valve replacement (TAVR) is an effective treatment for severe symptomatic aortic stenosis (AS) in patients who are inoperable or at high risk for surgery. However, the intermediate- to...
6.
Aortic root rupture after TAVR in two renal transplant patients on chronic immunosuppressant therapy
Holper E, Kim R, Brooks A, Mack M
Catheter Cardiovasc Interv
. 2014 Apr;
85(5):909-15.
PMID: 24740848
Patients on chronic immunosuppressant therapy after renal transplantation have a high rate of in-hospital mortality and approximately 20% mortality rate per year after conventional valve surgery. While transcatheter aortic valve...
7.
Kim R, McGehee E, Mack M
Catheter Cardiovasc Interv
. 2013 Jun;
83(1):E146-9.
PMID: 23766133
Acute left main coronary occlusion secondary to a periaortic root hematoma secondary to annular rupture during transcatheter heart valve deployment is reported.
8.
Holper E, Kim R, Mack M, Brown D, Brinkman W, Herbert M, et al.
Catheter Cardiovasc Interv
. 2013 May;
83(3):457-64.
PMID: 23703878
Objectives: To compare iliofemoral arterial complications with transfemoral transcatheter aortic valve replacement (TF-TAVR) utilizing surgical cutdown versus percutaneous access with closure devices in a randomized trial. Background: Major vascular complications...